Breakthroughs in hepatitis C research: from discovery to cure
MP Manns, B Maasoumy - Nature reviews Gastroenterology & …, 2022 - nature.com
In the 1970s, an unknown virus was suspected for documented cases of transfusion-
associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious …
associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious …
Hepatitis C virus infection
MP Manns, M Buti, ED Gane, JM Pawlotsky… - Nature reviews Disease …, 2017 - nature.com
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
[PDF][PDF] Diagnosis, management, and treatment of hepatitis C: an update
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
M Omata, LA Lesmana, R Tateishi, PJ Chen… - Hepatology …, 2010 - Springer
Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …
convened an international working party on the management of hepatocellular carcinoma …
Global epidemiology of hepatitis C virus infection
CW Shepard, L Finelli, MJ Alter - The Lancet infectious diseases, 2005 - thelancet.com
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of
substantial morbidity and mortality in the future. The complexity and uncertainty related to …
substantial morbidity and mortality in the future. The complexity and uncertainty related to …
[PDF][PDF] Diagnosis, management, and treatment of hepatitis C
DB Strader, T Wright, DL Thomas, LB Seeff - Hepatology, 2004 - Wiley Online Library
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. In the United States, the Centers for Disease Control and …
cause of chronic liver disease. In the United States, the Centers for Disease Control and …
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld, JH Hoofnagle - Nature, 2005 - nature.com
Since the identification of the hepatitis C virus, great strides have been made in the
development of an antiviral therapy. As a crucial mediator of the innate antiviral immune …
development of an antiviral therapy. As a crucial mediator of the innate antiviral immune …
Biologics for targeting inflammatory cytokines, clinical uses, and limitations
P Rider, Y Carmi, I Cohen - International journal of cell biology, 2016 - Wiley Online Library
Proinflammatory cytokines are potent mediators of numerous biological processes and are
tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and …
tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and …
Viral hepatitis C
Epidemiology Chronic hepatitis C virus infection is a major cause of chronic liver disease
and death throughout the world. 1, 2, 4–9 Very effective treatment is now available, which …
and death throughout the world. 1, 2, 4–9 Very effective treatment is now available, which …